What is Odyssey Therapeutics, Inc.'s market cap?

Odyssey Therapeutics, Inc. (ODTX) has a market capitalization of $916.0M and trades on XNAS.

Where is Odyssey Therapeutics, Inc. headquartered?

Odyssey Therapeutics, Inc. is headquartered in United States of America. It has been publicly traded since 2026.

ODT

Odyssey Therapeutics, Inc.

ODTX

Odyssey Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Gary D. Glick, with a market cap of $916.0M.

Market cap

$915.96M+18.2%

Table of contents

Earnings

Q2 2026 report

June 17, 2026

EPS-$6.77Miss by $5.66

Read the full report

Next report

Sep 16, 2026 (in 3 months)

EPS estimate-$0.89

Financials

Q2 2026

Income statement

See full

Revenue--100%

Operating income-$39.8M-1.6%

Net income-$38.3M+0.5%

EPS (diluted)-$6.77+82.8%

Balance sheet

See full

Cash & equivalents$35.7M-35.0%

Total debt$26.1M—

Total equity-$523.7M-25.5%

Total assets$229.1M—

Cash flow

See full

Operating cash flow-$41.0M-6.3%

CapEx$148.0K-84.0%

Free cash flow-$41.2M-4.1%

Valuation & ratios

Valuation

See full

Market cap$915.96M—

Enterprise value$906.37M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio8.3×—

Profile

CountryUnited States of America

Listed2026

CEOGary D. Glick

SectorHealthcare

IndustryBiotechnology

Websiteodysseytx.com

FilingsSEC EDGAR

Questions, answered.

What is Odyssey Therapeutics, Inc.'s market cap?: Odyssey Therapeutics, Inc. (ODTX) has a market capitalization of $916.0M and trades on XNAS.
Where is Odyssey Therapeutics, Inc. headquartered?: Odyssey Therapeutics, Inc. is headquartered in United States of America. It has been publicly traded since 2026.